These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10518684)

  • 1. Lysosubtilin modification, Fermosorb, designed for polymeric carrier-mediated intestinal delivery of lytic enzymes: pilot-scale preparation and evaluation of this veterinary medicinal product.
    Biziulevicius GA; Zukaite V
    Int J Pharm; 1999 Oct; 189(1):43-55. PubMed ID: 10518684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies on Polyferm and Fermosorb, two oral (ferment + sorbent) - type preparations designed for therapy/prophylaxis of intestinal infections in animal neonates.
    Biziulevicius GA; Zukaite V
    J Vet Pharmacol Ther; 2001 Dec; 24(6):433-8. PubMed ID: 11903874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antimicrobial activity of lysosubtilin and its acid-resistant derivative, Fermosorb.
    Biziulevièius GA; Sukaitë V
    Int J Antimicrob Agents; 2002 Jul; 20(1):65-8. PubMed ID: 12127714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication of oral acid resistant Fermosorb (Ferment + sorbent)-type preparations can be simplified using industrial Bacillus subtilis culture filtrates as an enzyme source.
    Biziulevicius GA; Zukaite V
    Int J Pharm; 2000 Aug; 204(1-2):43-6. PubMed ID: 11011984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo studies on lysosubtilin. I. Efficacy for prophylaxis and treatment of gastrointestinal disorders in newborn calves.
    Biziulevichius GA; Arestov IG
    Vet Res; 1997; 28(1):19-35. PubMed ID: 9172838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo studies on lysosubtilin. 3. Efficacy for treatment of mastitis and superficial lesions of the udder and teats in cows.
    Biziulevichius GA; Lukauskas K
    Vet Res; 1998; 29(5):441-56. PubMed ID: 9779557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-specific immunity-enhancing effects of tryptic casein hydrolysate versus Fermosorb for treatment/prophylaxis of newborn calf colibacillosis.
    Biziulevicius GA; Zukaite V; Normantiene T; Biziuleviciene G; Arestov IG
    FEMS Immunol Med Microbiol; 2003 Nov; 39(2):155-61. PubMed ID: 14625099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of lysosubtilin per os in mice, rabbits and calves.
    Biziulevichius GA; Arestov IG
    Vet Res; 1997; 28(4):385-95. PubMed ID: 9257446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo studies on lysosubtilin. 2. Efficacy for treatment of post-partum endometritis in cows.
    Biziulevichius GA; Lukauskas K
    Vet Res; 1998; 29(1):47-58. PubMed ID: 9559520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lysosubtilin G10x--a new antimicrobial agent for treatment and prophylaxis. Physico-chemical properties].
    Biziuliavichius GA; Shablinskas AI; Zhukaĭte VP; Kislukhina OV
    Antibiot Med Biotekhnol; 1987 May; 32(5):331-3. PubMed ID: 3111353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of microbial autolytic system by tryptic casein hydrolysate.
    Biziulevicius GA; Kislukhina OV; Zukaite V; Normantiene T; Arestov IG
    Int J Antimicrob Agents; 2002 Nov; 20(5):361-5. PubMed ID: 12431871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibacterial spectrum of lisosubtilin G10X].
    Biziuliavichius GA; Shablinskas AI; Zhukaĭte VP; Kislukhina OV
    Antibiot Khimioter; 1989 Aug; 34(8):579-81. PubMed ID: 2511813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of lytic enzyme production resulting from replacement of the usual morphological variant of industrial lysosubtilin producer.
    Biziulevichius GA; Normantiene T
    Lett Appl Microbiol; 1997 Feb; 24(2):133-5. PubMed ID: 9081307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where do the immunostimulatory effects of oral proteolytic enzymes ('systemic enzyme therapy') come from? Microbial proteolysis as a possible starting point.
    Biziulevicius GA
    Med Hypotheses; 2006; 67(6):1386-8. PubMed ID: 16870353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative and qualitative analysis of antimicrobial usage in white veal calves in France.
    Jarrige N; Cazeau G; Morignat E; Chanteperdrix M; Gay E
    Prev Vet Med; 2017 Sep; 144():158-166. PubMed ID: 28716197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enteropathogenicity of E. coli strains isolated from calves].
    Petkov M
    Vet Med Nauki; 1980; 17(5):10-7. PubMed ID: 7015684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: Preparation of Poly(pentafluorophenyl acrylate) Functionalized SiO2 Beads for Protein Purification.
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31038480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal plants--prophylactic and therapeutic options for gastrointestinal and respiratory diseases in calves and piglets? A systematic review.
    Ayrle H; Mevissen M; Kaske M; Nathues H; Gruetzner N; Melzig M; Walkenhorst M
    BMC Vet Res; 2016 Jun; 12():89. PubMed ID: 27268043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility of Salmonella isolates recovered from calves with diarrhoea in Australia.
    Izzo M; Mohler V; House J
    Aust Vet J; 2011 Oct; 89(10):402-8. PubMed ID: 21933168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effective preparations in colibacillosis of calves and piglets].
    Petrov VM; Anan'ev PK; Gushul VA; Solov'ev EB; Shol' KhR
    Veterinariia; 1978 May; (5):53-6. PubMed ID: 354183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.